MACAU LEGEND (01680) plans to carry out a capital restructuring.
Macao Success (01680) announces that the company plans to undergo a capital restructuring to meet applicable Cayman Islands...
MACAU LEGEND (01680) announced that the company plans to undertake a capital restructuring in order to meet certain legal and procedural requirements under the laws of the Cayman Islands for the implementation of a proposed rights issue. The capital restructuring aims to optimize the company's capital structure and provide flexibility for future corporate actions.
Due to the need for additional time to complete the proposed capital restructuring, the expected timetable for the rights issue will be adjusted accordingly, and a supplemental agreement to the underwriting agreement has been entered into to reflect the capital restructuring and the revised timetable. The company hereby emphasizes that despite the updated action plan for the capital restructuring and the corresponding adjustment to the expected timetable, the company or the joint underwriters have not changed their intention to proceed with the rights issue.
Under the capital restructuring, the company intends to deregister in the Cayman Islands and, under Bermuda law, continue its existence as an exempted company, changing its place of registration from the Cayman Islands to Bermuda. This implementation will not affect the company's existence or its listing status on the Stock Exchange. Upon the effectiveness of the change in place of registration, the company will reduce its share capital, resulting in a reduction of its issued share capital from a nominal or par value of HK$1.00 per share to HK$0.01 per share.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


